A detailed history of Willner & Heller, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Willner & Heller, LLC holds 7,020 shares of MRNA stock, worth $251,947. This represents 0.26% of its overall portfolio holdings.

Number of Shares
7,020
Previous 7,295 3.77%
Holding current value
$251,947
Previous $487,000 40.25%
% of portfolio
0.26%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

SELL
$36.85 - $63.93 $10,133 - $17,580
-275 Reduced 3.77%
7,020 $291,000
Q3 2024

Oct 10, 2024

BUY
$63.64 - $125.14 $464,253 - $912,896
7,295 New
7,295 $487,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Willner & Heller, LLC Portfolio

Follow Willner & Heller, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willner & Heller, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Willner & Heller, LLC with notifications on news.